Population genetic studies have also linked ABCB4 variants to the development of inflammatory cholangiopathies, sclerosing cholangitis, and cirrhosis [14] that are already considered to predispose to cholangiocarcinoma [16–18, 21, 22]. Here, ABCB4 is linked to sclerosing cholangitis.